information were not provided; (3) reviews and duplicated publications; (4) family-based studies of pedigrees with several affected cases per family; and (5) studies that did not discriminate between GD and HT. After searching, we reviewed all papers in accordance with the criteria defined above for further analysis.
Data extraction
Two of the authors independently extracted data from all eligible publications and reached consensus on potential disagreements. The following information was sought from each report: first authors; year of publication; country of origin; selection and characteristics of cases and controls; demographics; "racial" descent of the study population (Asian and Caucasian); the study design whether thyroid antibody status was ascertained in controls: Ab (-) represent thyroid antibody status was ascertained in controls and subjects with thyroid antibody were excluded from control, and Ab (±) represent thyroid antibody status was not ascertained in controls; eligible and genotyped cases and controls; and genotype distributions. Whenever a study team included two or more "racial" descent subgroups, these were treated as separate studies in all analyses. For conflicting evaluations, a final consensus was obtained following a discussion.
Statistical analyses
Primary analyses compared allele frequencies for each polymorphism. We also addressed codominant model (C ⁄ C vs. T ⁄ T, C/T vs. T/T), recessive(C ⁄ C vs.
C ⁄ T+T⁄ T) and dominant models (C ⁄ C+C ⁄ T vs. T⁄ T).
The odds ratio (OR) was used as the metric of choice. The effect of association was indicated as OR with the corresponding 95% confidence interval (CI ). Heterogeneity across all eligible comparisons was tested using the chi square-based Q statistic [17] . A p-value >0.05 for the Q-test indicated a lack of heterogeneity among studies, so the pooled OR estimate of the each study was calculated by the fixed-effects model (Mantel-Haenszel method) [18] . Otherwise, the random-effects model (DerSimonian and Laird method) [19] was used. Subgroup analyses estimated ORs per "racial" descent subgroup and per "study design" subgroup respectively.
Sensitivity analysis was performed to assess the stability of the results. A single study involved in the meta-analysis was deleted each time to reflect the influence of the individual data set to the pooled ORs.
EAT) induced by injection with thyroglobulin, indicating CD40 being relate to HT [11, 12] .
Whole-genome linkage scanning and the further sequencing studies demonstrated that a C/T SNP in the Kozak sequence of CD40 (CD40 C/T-1) was the likely causative variant predisposing to GD [13, 14] . Indeed, in vitro experiments, the translation of CD40 mRNA transcripts increased 20%~30% by the C-allele of the polymorphism compared to the T-allele [15, 16] . However, the following studies investigating the association between the risk of GD and CD40 C allele demonstrate inconsistent results and their relative population effect remains unclear. Different to GD, CD40 C/T-1 gene polymorphism has not been found associated with HT. Due to that most studies include only small numbers of cases and controls, it is possible the negative results be a consequence of low statistical power. To determine the effects of this polymorphism on the risk of AITD, we have undertaken a meta-analysis.
Materials and Methods

Identification of studies
We first identified all published studies that examined the association of any CD40 gene polymorphism with AITDs through conducting a literature search of the Pubmed, CNKI (China National Knowledge Infrastructure) and Wanfang databases (last search update performed in March 2012). The search strategy was based on combinations of "CD40," "TNFRSF5," "TNF receptor super family member 5," "polymorphism," "thyroid," "Graves," "Hashimoto," and "Autoimmune thyroid disease" limited to humans without language restriction. References of retrieved articles were also screened.
Selection criteria
The following criteria were used for selection of reports for the meta-analysis: (1) studies were eligible if they had determined the distribution of alleles and genotypes for CD40 -C/T polymorphism in unrelated cases with GD or HT and in unrelated controls without AITDs; (2) case-control studies; and (3) genotype distribution of control population in studies had to be in Hardy-Weinberg equilibrium (HWE). Accordingly, the following exclusion criteria were also used: (1) the design and the definition of the experiments were obviously different from those of the selected papers; (2) the source of cases and controls and other essential
Results
Eligible studies
The electronic search yielded 32 articles, but only 14 studies met our inclusion criteria, as listed in Table 1 [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] . Eighteen studies were excluded for the following reasons: five studies neither contain exact genotype distribution information nor be case-control studies [15, [37] [38] [39] [40] ; ten studies were reviews [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] ; two studies were duplicated [14, 51] and in one study [52] , genotype distributions in control population deviated from the Hardy-Weinberg equilibrium. The data for this analysis were derived from 14 studies, including 4,214 cases and 3,851 controls for GD disease from 14 studies, and 623 cases and 774 controls for HT from 4 studies. Five studies matched for ethnical descent, age, gender and geographic region [23, 24, 31, 34, 36] , one for ethnical descent, gender and geographic region [33] , and others for ethnical descent and geographic region [25-30, 32, 35] . Sequence [33] and PCR-RFLP methods were used for genotyping. No articles mentioned explicit blinding of the personnel that performed the genotyping. Table 1 An estimate of potential publication bias was assessed by visual inspection of funnel plots [20] , in which the standard error of log (OR) of each study was plotted against its log (OR). An asymmetric plot indicates a possible publication bias. The symmetry of the funnel plot was further evaluated by Egger's linear regression test ( p < 0.05 was considered indicative of significant publication bias) [21] . We also performed the Duval and Tweedie nonparametric "trim and fill" procedure to further assess the possible effect of publication bias in our meta-analysis [22] . This method considers the possibility of hypothetical "missing" studies that might exist, imputes their ORs, and recalculates a pooled OR that incorporates the hypothetical missing studies as though they actually existed. To test for population stratification, the distribution of genotypes in control subjects of each individual population was tested for departure from the Hardy-Weinberg equilibrium using the chi square-test. Statistical analysis was performed using STATA version 10.1 (Stata Corporation, College Station, TX, USA). 0.111) with evidence of significant between-study heterogeneity (Table 2) . When stratified by study design, statistically significant association of polymorphism and GD was found both in Ab (-) study (C vs. T: OR = 1.477 95% CI, 1.194~1.828) and Ab (±) study (C vs. T: OR = 1.141 95% CI, 1.050~1.239). The details are listed in Table 2 .
The individuals who carried the C ⁄ C or C/T genotype have significantly increased GD risk compared with those who carried T⁄T genotype (C ⁄ C vs. T/T: OR = 1.596, 95% CI, 1.256~2.028; C ⁄ T vs. T/T: OR = 1.210, 95% CI, 1.032~1.419); and the significant association was also found in the dominant model (OR = 1.366, 95% CI, 1.175~1.587) or recessive model (OR = 1.322, 95% CI, 1.147~1.523). Then, the 14 studlists the identified studies and their main characteristics.
Meta-analysis results
To summarize the published data, we did a comprehensive meta-analysis. The overall data showed that a 1.267-fold increase in susceptibility to GD among subjects with the C allele (p = 0.000) but with evidence of substantial between-study heterogeneity (p = 0.004 for heterogeneity, I 2 = 57.6%) ( Table 2 , Fig. 1 ). Then, subgroups analysis of different racial descent was performed. The significant association between C allele and GD risk was still found in Asians (p = 0.000) with evidence of significant between-study heterogeneity (p = 0.030 for heterogeneity, I 2 = 52.9%) ( Table 2 ). However, there was no association in Caucasians (p = In the stratified analysis of study design, significant increased GD risk was found both in Ab (-) study and Ab (±) study for the dominant model, but only in Ab (-) study for the recessive model. The details are listed in Table 2 . The C allele conferred none increase in the susceptibility of HT (p = 0.332), and there was no betweenstudy heterogeneity (p = 0.599 for heterogeneity; I 2 = 0%; Table 3 and Fig. 1 ). Similar effects were found for genotype analysis that the individuals who carried the C ⁄C or C/T genotype did not have significantly higher HT risk compared with those who carried T⁄ T genotype; and no significant association was found in the dominant model or recessive model. In the subgroup analysis of study design, there was no significant association between polymorphism and HT risk. The details are listed in Table 3 .
Sensitivity analyses
Sensitivity analyses were conducted to determine whether modification of the inclusion criteria of the meta-analysis affected the final results. These were carried out by limiting the meta-analysis to studies conforming to HWE and altering corresponding statistic variables and analysis models. No results were materially altered (data not shown).
Publication bias
Begg's funnel plots and Egger's tests were performed to assess publication bias. The shapes of the funnel plots revealed no obvious asymmetry. Egger's test was then used to statistically assess funnel plot symmetry. The results suggested no evidence of publication bias (GD: p = 0.388 for allele model; p = 0.355 for additive model; and p =0.43 for recessive model; p = 0.519 for dominant model; HT: p = 0.255 for allele model; p = 0.925 for additive model; p = 0.697 for recessive model; p = 0.65 for dominant model). In subgroups analysis of GD, the Asian results suggest the possibility of publication bias. Because of this, we undertook a sensitivity analysis using the trim and fill method, which conservatively imputed hypothetical negative unpublished studies to mirror the positive studies that caused funnel plot asymmetry. The imputed studies produced a symmetrical funnel plot. The pooled analysis incorporating the hypothetical studies continued to show a statistically significant association the same as before. The results indicated that the results of these meta-analyses are relatively ies were analyzed by stratification based on ethnicity and study design. In the subgroup analysis of ethnicity, the significant association between polymorphism and GD risk of Caucasians was found only in recessive models but not in other models (recessive model: OR stable and that publication bias is unlikely to affect the results of the meta-analyses. Fig. 2 displayed a funnel plot that examined the CD40 -C/T polymorphism and susceptibility to GD (C vs. T) in Asians without and with trim and fill. Although visual inspection of the Begg funnel plot did not reveal asymmetry (p =0.053) ( Fig. 2A) , the Begg test was statisitically significant (z=1.98; p =0.048).This raises the possibility of publication bias. Then, the imputed studies produced a symmetrical funnel plot (Fig. 2B) .
Discussion
CD40, a member of tumor necrosis factor (TNF) receptor superfamily, is expressed by immune and nonimmune cells and involves mediating T-dependent B cell responses and efficient T cell priming. Thus, CD40 plays a pathogenic role in various autoimmune diseases, for example, autoimmune thyroiditis, multiple sclerosis (MS), rheumatoid arthritis, systemic lupus erythematosus and so on [45] .
Tomer et al. first examined the association between the CD40 C/T-1 Kozak SNP and the risk of GD [14] . After that, the case-control studies provided controversial results. In 2004, when investigated within two independent and much larger UK Caucasian datasets (800 GD patients and 735 control subjects and 451 GD patients and 446 control subjects, respectively), no evidence for association of the C allele of CD40 Kozak 
Fig. 2 Funnel Plots of CD40 -C/T polymorphism and susceptibility to GD (C vs. T) in Asians without and with trim and till
The pseudo 95% CI is computed as part of the analysis that produces the funnel plot, and corresponds to the expected 95% CI for a given standard error (SE).
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SNP was reported [24, 25, 32] . In 2005~2008, three papers also got distinct results in Asia population [26, 32, 33] . In 2003, Kim et al. first examined the association between the CD40 C/T-1 polymorphism and the risk of HT (118 HT patients and 164 normal controls), and allele frequencies in CD40 C/T-1 did not differ from controls in patients with HT [28] . However, it is known that individual studies with a small sample size may have not enough statistical power to detect a small risk factor. To clarify these questions, we collected all the studies in PubMed, CNKI and Wanfang, carried out a meta-analysis to examine the association of CD40 C/T-1 polymorphisms with susceptibility to GD and HT. Our current pooled data involved a total of 4,214 cases and 3,851 controls for GD disease and 623 cases and 774 controls for HT. We found that there were significant associations between the CD40 C/T-1 polymorphism and GD risk. However, individuals who carried the C ⁄ C or C ⁄ T genotype had no significant different HT risk compared with the T⁄T carriers.
The results showed that CD40 C/T-1 polymorphism plays different role in GD and HT.
In vivo CD40 activity is important for the induction of experimental autoimmune thyroiditis [11] . In HT patients, CD40 serum concentration is significantly higher [53] . However, molecular epidemiologic evidence has shown that this polymorphism was associated with an increased risk of GD but not HT. Our meta-analysis found T allele of CD40 C/T-1 polymorphism was respectively 40.5% and 39% in HT patients and controls with a lower power. Buck et al. observed a similar increase in the minor allele frequency in MS patients when compared to controls (33% vs. 29%), although a limited statistical power prevented them from reaching the significance threshold [54] . Subsequently, Blanco-Kelly et al. replicated this effect in an independent MS cohort (1,564 patients and 2,948 controls) and corroborated the association of the minor allele of this polymorphism in MS risk (MS vs. Control: 29% vs. 27%, p =0.025) [55] . Including a recently performed genome-wide association study [56] , they all proved that the susceptibility allele C described for GD or rheumatoid arthritis seemed to protect against MS and Crohn's disease (CD), suggestive of a different molecular mechanism involved in the aetiology of these conditions. Based on this knowledge, CD40 C/T-1 polymorphism can act as both the risk and protect factor in immune-mediated diseases. When our meta-analysis found C allele of CD40 C/T-1 polymorphism had no significant susceptibility to HT, we also found the minor allele T frequency was higher in HT patients than in controls (40.5% vs. 39%). However, it is possible due to the still lower power (623 cases and 774 controls), we did not see the significant difference. As CD40 could induce CD8 (+) Treg which play important roles in the maintenance of immune tolerance [57] , further research regarding the balance of effector and regulatory T cells will help to ascertain the pleiotropic action of CD40 signaling exerted on several immunemediated diseases. In addition, another polymorphism site but not CD40 C/T-1 in CD40 may be the target polymorphism associated with HT. They all should be emphasized in future research.
In the subgroup analysis of racial descent, the significant association between polymorphism and GD risk of Caucasians was found only in recessive models but not in other models; but that of Asians was found in all models. This may be due to the fact that the ethnicity difference. In the subgroup analysis of study design, the individuals carrying the C ⁄ C genotype showed a higher GD risk compared with those with the (C ⁄ T+T ⁄ T) genotype for Ab (-) study, but not for the Ab (±) studies. This may be due to the fact that the Ab (±) studies may have some biases when thyroid antibody status was not ascertained in controls. So the controls may include subjects with euthyroidism, no history of thyroid disorders and other autoimmune diseases but positive for thyroid-specific autoantibodies and are not truly representative of the normal population. Therefore, it is necessary to take into account the thyroid-specific autoantibody status of control subjects in the study design, especially for the HT study. HT is often associated with the high level of either TPOAb or TgAb and have hypothyroidism or euthyroidism. Ban et al. defined only hypothyroidism as HT and did not consider euthyroidism subjects with thyroid autoantibody in controls. So we excluded Ban's study, did the subgroup analysis in Ab (-) study and found there was no significant association between polymorphism and HT risk. This analysis found T allele of CD40 C/T-1 polymorphism was respectively 40.3% and 38.6% in HT patients and controls with still a lower power. However, this indicated that we should note that subjects with euthyroidism and high level autoantibody should be excluded from controls and included into HT.
There are some limitations to this meta-analysis. Firstly, heterogeneity for CD40 C/T-1 polymorphism among the studies was extreme. This could be the trim and fill sensitivity analysis did not change the general result (although the strength of the association was slightly attenuated), suggesting that the association is not an artifact of unpublished negative studies. In other databases, no publication bias was detected, indicating that the pooled result should be reliable.
In conclusion, pooled analysis of data from 14 (GD) or 4 (HT) articles indicated that the CD40 C alleles have association with GD but not HT. The results implied that different immune-mediated diseases involve different pathological pathways and the role of CD40 in immune-mediated diseases is pleiotropic. due to chance, genuine diversity of genetic effects or that Asian and European ethnicities are respectively extremely extensive. Furthermore, only published studies are included in the meta-analysis and it is possible that some related unpublished studies are missed. Therefore publication bias may have been present, even though statistical analysis indicated this not to be the case. In addition, our results were based on unadjusted estimates and a more precise analysis could have been conducted if individual data were available, which would allow for adjustment by other covariates such as age, ethnicity, environmental factors, and lifestyle. Lastly, in the subgroup analyses, there was no Caucasian study on HT and the number of Asians was relatively small for HT to explore the association of the polymorphism with HT susceptibility. However, our meta-analysis also had some advantages. A substantial number of cases and controls were pooled from different studies, which significantly increased the statistical power of the analysis. Although the funnel plot analysis of Asia databases showed some asymmetry,
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